project id: TCGA-ESCA; case submitter id: TCGA-R6-A6XQ; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.58; rna integrity number: 7.5; age at index: 58; days to birth: -21410; days to death: 193; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1950; year of death: 2008; age at diagnosis: 21410; ajcc clinical m: M1b; ajcc clinical n: N1; ajcc clinical stage: Stage IVB; ajcc clinical t: T3; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C15.5; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower third of esophagus; synchronous malignancy: No; tissue or organ of origin: Lower third of esophagus; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: no; alcohol history: Yes; cigarettes per day: 2.958904109589041; pack years smoked: 54.0; is ffpe: false; weight: 5.0; composition: Not Reported; days to collection: 1810; days to sample procurement: 0; initial weight: 5.0; sample id: 610d9004-db0b-4c8e-9c1d-7eebfae5b570; sample submitter id: TCGA-R6-A6XQ-01B; portion id: 472c7a9b-b37b-4514-ae6c-fd7dd883e63b; portion submitter id: TCGA-R6-A6XQ-01B-11; slide id: 16b81d33-0108-4cc1-be9a-daadd07f6841; slide submitter id: TCGA-R6-A6XQ-01Z-00-DX1; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 2.0; percent necrosis: 0.0; percent neutrophil infiltration: 4.0; percent normal cells: 2.0; percent stromal cells: 33.0; percent tumor cells: 65.0; percent tumor nuclei: 95.0; section location: TOP;